EPR Spectroscopy of a Clinically Active (1:2) Copper(II)-Histidine Complex Used in the Treatment of Menkes Disease: A Fourier Transform Analysis of a Fluid CW-EPR Spectrum

Redox active transition metal ions (e.g., iron and copper) have been implicated in the etiology of many oxidative stress-related diseases including also neurodegenerative disorders. Unbound copper can catalyze formation of reactive oxygen species (hydroxyl radicals) via Fenton reaction/Haber–Weiss c...

Full description

Bibliographic Details
Main Authors: Lukas Gala, Michael Lawson, Klaudia Jomova, Lubomir Zelenicky, Andrea Congradyova, Milan Mazur, Marian Valko
Format: Article
Language:English
Published: MDPI AG 2014-01-01
Series:Molecules
Subjects:
Online Access:http://www.mdpi.com/1420-3049/19/1/980
id doaj-efc3dbc14a354b508321def6155cbfb1
record_format Article
spelling doaj-efc3dbc14a354b508321def6155cbfb12020-11-24T23:15:34ZengMDPI AGMolecules1420-30492014-01-0119198099110.3390/molecules19010980molecules19010980EPR Spectroscopy of a Clinically Active (1:2) Copper(II)-Histidine Complex Used in the Treatment of Menkes Disease: A Fourier Transform Analysis of a Fluid CW-EPR SpectrumLukas Gala0Michael Lawson1Klaudia Jomova2Lubomir Zelenicky3Andrea Congradyova4Milan Mazur5Marian Valko6Faculty of Chemical and Food Technology, Slovak Technical University, Bratislava SK-812 37, SlovakiaFaculty of Chemical and Food Technology, Slovak Technical University, Bratislava SK-812 37, SlovakiaFaculty of Natural Sciences, Constantine The Philosopher University, Nitra SK-949 74, SlovakiaFaculty of Natural Sciences, Constantine The Philosopher University, Nitra SK-949 74, SlovakiaFaculty of Natural Sciences, Constantine The Philosopher University, Nitra SK-949 74, SlovakiaFaculty of Chemical and Food Technology, Slovak Technical University, Bratislava SK-812 37, SlovakiaFaculty of Chemical and Food Technology, Slovak Technical University, Bratislava SK-812 37, SlovakiaRedox active transition metal ions (e.g., iron and copper) have been implicated in the etiology of many oxidative stress-related diseases including also neurodegenerative disorders. Unbound copper can catalyze formation of reactive oxygen species (hydroxyl radicals) via Fenton reaction/Haber–Weiss chemistry and therefore, under physiological conditions, free copper is potentially toxic and very rarely exists inside cells. Copper(II) bound to the aminoacid L-histidine represents a species discovered in blood in the mid 60s and since then extensive research on this complex was carried out. Copper bound to L-histidine represents an exchangeable pool of copper(II) in equilibrium with the most abundant blood plasma protein, human serum albumin. The structure of this complex, in aqueous solution, has been a subject of many studies and reviews, however without convincing success. The significance of the (1:2) copper(II)-L-histidine complex at physiological pH documents its therapeutic applications in the treatment of Menkes disease and more recently in the treatment of infantile hypertrophic cardioencephalomyopathy. While recently the (1:2) Cu(II)-L-His complex has been successfully crystallized and the crystal structure was solved by X-ray diffraction, the structure of the complex in fluid solution at physiological pH is not satisfactorily known. The aim of this paper is to study the (1:2) Cu(II)-L-histidine complex at low temperatures by X-band and S-band EPR spectroscopy and at physiological pH at room temperature by Fourier transform CW-EPR spectroscopy.http://www.mdpi.com/1420-3049/19/1/980copper-histidine complexcopper metabolismMenkes diseaseEPR spectroscopyFT-EPR spectroscopy
collection DOAJ
language English
format Article
sources DOAJ
author Lukas Gala
Michael Lawson
Klaudia Jomova
Lubomir Zelenicky
Andrea Congradyova
Milan Mazur
Marian Valko
spellingShingle Lukas Gala
Michael Lawson
Klaudia Jomova
Lubomir Zelenicky
Andrea Congradyova
Milan Mazur
Marian Valko
EPR Spectroscopy of a Clinically Active (1:2) Copper(II)-Histidine Complex Used in the Treatment of Menkes Disease: A Fourier Transform Analysis of a Fluid CW-EPR Spectrum
Molecules
copper-histidine complex
copper metabolism
Menkes disease
EPR spectroscopy
FT-EPR spectroscopy
author_facet Lukas Gala
Michael Lawson
Klaudia Jomova
Lubomir Zelenicky
Andrea Congradyova
Milan Mazur
Marian Valko
author_sort Lukas Gala
title EPR Spectroscopy of a Clinically Active (1:2) Copper(II)-Histidine Complex Used in the Treatment of Menkes Disease: A Fourier Transform Analysis of a Fluid CW-EPR Spectrum
title_short EPR Spectroscopy of a Clinically Active (1:2) Copper(II)-Histidine Complex Used in the Treatment of Menkes Disease: A Fourier Transform Analysis of a Fluid CW-EPR Spectrum
title_full EPR Spectroscopy of a Clinically Active (1:2) Copper(II)-Histidine Complex Used in the Treatment of Menkes Disease: A Fourier Transform Analysis of a Fluid CW-EPR Spectrum
title_fullStr EPR Spectroscopy of a Clinically Active (1:2) Copper(II)-Histidine Complex Used in the Treatment of Menkes Disease: A Fourier Transform Analysis of a Fluid CW-EPR Spectrum
title_full_unstemmed EPR Spectroscopy of a Clinically Active (1:2) Copper(II)-Histidine Complex Used in the Treatment of Menkes Disease: A Fourier Transform Analysis of a Fluid CW-EPR Spectrum
title_sort epr spectroscopy of a clinically active (1:2) copper(ii)-histidine complex used in the treatment of menkes disease: a fourier transform analysis of a fluid cw-epr spectrum
publisher MDPI AG
series Molecules
issn 1420-3049
publishDate 2014-01-01
description Redox active transition metal ions (e.g., iron and copper) have been implicated in the etiology of many oxidative stress-related diseases including also neurodegenerative disorders. Unbound copper can catalyze formation of reactive oxygen species (hydroxyl radicals) via Fenton reaction/Haber–Weiss chemistry and therefore, under physiological conditions, free copper is potentially toxic and very rarely exists inside cells. Copper(II) bound to the aminoacid L-histidine represents a species discovered in blood in the mid 60s and since then extensive research on this complex was carried out. Copper bound to L-histidine represents an exchangeable pool of copper(II) in equilibrium with the most abundant blood plasma protein, human serum albumin. The structure of this complex, in aqueous solution, has been a subject of many studies and reviews, however without convincing success. The significance of the (1:2) copper(II)-L-histidine complex at physiological pH documents its therapeutic applications in the treatment of Menkes disease and more recently in the treatment of infantile hypertrophic cardioencephalomyopathy. While recently the (1:2) Cu(II)-L-His complex has been successfully crystallized and the crystal structure was solved by X-ray diffraction, the structure of the complex in fluid solution at physiological pH is not satisfactorily known. The aim of this paper is to study the (1:2) Cu(II)-L-histidine complex at low temperatures by X-band and S-band EPR spectroscopy and at physiological pH at room temperature by Fourier transform CW-EPR spectroscopy.
topic copper-histidine complex
copper metabolism
Menkes disease
EPR spectroscopy
FT-EPR spectroscopy
url http://www.mdpi.com/1420-3049/19/1/980
work_keys_str_mv AT lukasgala eprspectroscopyofaclinicallyactive12copperiihistidinecomplexusedinthetreatmentofmenkesdiseaseafouriertransformanalysisofafluidcweprspectrum
AT michaellawson eprspectroscopyofaclinicallyactive12copperiihistidinecomplexusedinthetreatmentofmenkesdiseaseafouriertransformanalysisofafluidcweprspectrum
AT klaudiajomova eprspectroscopyofaclinicallyactive12copperiihistidinecomplexusedinthetreatmentofmenkesdiseaseafouriertransformanalysisofafluidcweprspectrum
AT lubomirzelenicky eprspectroscopyofaclinicallyactive12copperiihistidinecomplexusedinthetreatmentofmenkesdiseaseafouriertransformanalysisofafluidcweprspectrum
AT andreacongradyova eprspectroscopyofaclinicallyactive12copperiihistidinecomplexusedinthetreatmentofmenkesdiseaseafouriertransformanalysisofafluidcweprspectrum
AT milanmazur eprspectroscopyofaclinicallyactive12copperiihistidinecomplexusedinthetreatmentofmenkesdiseaseafouriertransformanalysisofafluidcweprspectrum
AT marianvalko eprspectroscopyofaclinicallyactive12copperiihistidinecomplexusedinthetreatmentofmenkesdiseaseafouriertransformanalysisofafluidcweprspectrum
_version_ 1725590486913122304